Activation of dendritic antigen‐presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis

Background  Psoriasis is a common and chronic relapsing inflammatory skin disorder. Although a role for T cells in mediating the induction and maintenance of psoriatic lesions is well established, mechanisms responsible for activation of T cells by antigen‐presenting cells (APCs) during disease relapse are poorly understood.

[1]  P. Srivastava,et al.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. , 2001, Immunity.

[2]  J. Barker,et al.  Pathophysiology of psoriasis. , 1977, Annual review of medicine.

[3]  Frank O. Nestle,et al.  Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α , 2004, The Journal of experimental medicine.

[4]  Liangji Zhou,et al.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  F. Nestle,et al.  Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. , 1994, The Journal of clinical investigation.

[6]  R. Morimoto,et al.  Expression of human HSP70 during the synthetic phase of the cell cycle. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Ohashi,et al.  Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo , 2003, Nature Medicine.

[8]  B. Nickoloff.  Skin innate immune system in psoriasis: friend or foe? , 1999, The Journal of clinical investigation.

[9]  J. Ovigne,et al.  Normal keratinocytes express Toll‐like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis , 2003, The British journal of dermatology.

[10]  June K. Robinson,et al.  Innate immune-related receptors in normal and psoriatic skin. , 2003, Archives of pathology & laboratory medicine.

[11]  A. Bowcock,et al.  Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and "Type 1" inflammatory gene expression. , 2004, Trends in immunology.

[12]  P. Srivastava,et al.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.

[13]  J. Voorhees,et al.  Psoriasis, T Cells and Autoimmunity , 1996, Journal of the Royal Society of Medicine.

[14]  B. Nickoloff,et al.  Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.

[15]  J. Fraki,et al.  Transplantation of psoriatic skin onto nude mice. , 1983, The Journal of investigative dermatology.

[16]  P. Srivastava,et al.  Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. , 2002, Annual review of immunology.

[17]  B. Gazzard,et al.  Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. , 2003, Blood.

[18]  J. Gudjonsson,et al.  Immunopathogenic mechanisms in psoriasis , 2004, Clinical and experimental immunology.

[19]  C. Reis e Sousa,et al.  Toll-like receptors and dendritic cells: for whom the bug tolls. , 2004, Seminars in immunology.

[20]  D. Carlo,et al.  CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  U. Chaudhari,et al.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial , 2001, The Lancet.

[22]  S. Porcelli,et al.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.

[23]  P. Mease,et al.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial , 2000, The Lancet.

[24]  S. Pizzo,et al.  A CD91-Positive Subset of CD11c+ Blood Dendritic Cells: Characterization of the APC that Functions to Enhance Adaptive Immune Responses against CD91-Targeted Antigens 1 , 2004, The Journal of Immunology.

[25]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[26]  P. Matzinger,et al.  Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.

[27]  J. Krueger.  The immunologic basis for the treatment of psoriasis with new biologic agents. , 2002, Journal of the American Academy of Dermatology.

[28]  B. Gazzard,et al.  The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. , 2003, Blood.

[29]  W. Sterry,et al.  Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermis , 2004, Archives of Dermatological Research.

[30]  J. Nick,et al.  By Binding SIRPα or Calreticulin/CD91, Lung Collectins Act as Dual Function Surveillance Molecules to Suppress or Enhance Inflammation , 2003, Cell.

[31]  James G. Krueger,et al.  Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis , 1995, Nature Genetics.

[32]  Shizuo Akira,et al.  TLR signaling pathways. , 2004, Seminars in immunology.

[33]  H. Rammensee,et al.  The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor , 2000, European journal of immunology.